Report Belgium - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

Belgium - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Belgium: Vaccine Market 2024

Vaccine Market Size in Belgium

After two years of growth, the Belgian vaccine market decreased by 99.9% to less than $X in 2022. Over the period under review, consumption enjoyed strong growth. Vaccine consumption peaked at $X in 2018; however, from 2019 to 2022, consumption stood at a somewhat lower figure.

Vaccine Production in Belgium

In value terms, vaccine production fell remarkably to $X in 2022 estimated in export price. In general, production, however, recorded a prominent expansion. The most prominent rate of growth was recorded in 2015 with an increase of 260% against the previous year. Over the period under review, production hit record highs at $X in 2018; however, from 2019 to 2022, production stood at a somewhat lower figure.

Vaccine Exports

Exports from Belgium

In 2022, after six years of growth, there was significant decline in overseas shipments of vaccines for human medicine, when their volume decreased by -68.4% to X tons. Overall, exports, however, posted prominent growth. The pace of growth appeared the most rapid in 2021 when exports increased by 301%. As a result, the exports attained the peak of X tons, and then contracted sharply in the following year.

In value terms, vaccine exports reduced markedly to $X in 2022. Over the period under review, exports, however, posted resilient growth. The most prominent rate of growth was recorded in 2021 with an increase of 194%. As a result, the exports attained the peak of $X, and then reduced markedly in the following year.

Exports by Country

The Philippines (X tons) was the main destination for vaccine exports from Belgium, accounting for a 56% share of total exports. Moreover, vaccine exports to the Philippines exceeded the volume sent to the second major destination, Sri Lanka (X tons), fourfold. The third position in this ranking was held by Argentina (X tons), with an 11% share.

From 2012 to 2022, the average annual rate of growth in terms of volume to the Philippines amounted to +59.8%. Exports to the other major destinations recorded the following average annual rates of exports growth: Sri Lanka (+60.2% per year) and Argentina (+44.9% per year).

In value terms, the largest markets for vaccine exported from Belgium were the Philippines ($X), Argentina ($X) and Uzbekistan ($X), together comprising 86% of total exports. Sri Lanka, Tunisia, Mozambique, Togo, Rwanda and Zimbabwe lagged somewhat behind, together accounting for a further 9.7%.

Mozambique, with a CAGR of +380.7%, recorded the highest rates of growth with regard to the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The average vaccine export price stood at $X per kg in 2022, increasing by 112% against the previous year. Over the period under review, the export price showed a prominent expansion. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Argentina ($X per kg), while the average price for exports to Sri Lanka ($X per kg) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Uzbekistan (+33.5%), while the prices for the other major destinations experienced more modest paces of growth.

Vaccine Imports

Imports into Belgium

After three years of growth, supplies from abroad of vaccines for human medicine decreased by -15.2% to X tons in 2021. Overall, imports, however, enjoyed a resilient increase. The pace of growth appeared the most rapid in 2020 with an increase of 105%. As a result, imports reached the peak of X tons, and then shrank rapidly in the following year.

In value terms, vaccine imports surged to $X in 2021. Over the period under review, imports, however, posted a remarkable increase. The most prominent rate of growth was recorded in 2016 with an increase of 90%. Over the period under review, imports hit record highs in 2021 and are likely to see gradual growth in the near future.

Imports by Country

In 2021, Ireland (X tons) constituted the largest vaccine supplier to Belgium, with a 67% share of total imports. Moreover, vaccine imports from Ireland exceeded the figures recorded by the second-largest supplier, France (X tons), sevenfold. The third position in this ranking was held by Germany (X tons), with a 7.8% share.

From 2012 to 2021, the average annual growth rate of volume from Ireland totaled +24.4%. The remaining supplying countries recorded the following average annual rates of imports growth: France (-10.8% per year) and Germany (-8.5% per year).

In value terms, Ireland ($X) constituted the largest supplier of vaccines for human medicine to Belgium, comprising 59% of total imports. The second position in the ranking was taken by Spain ($X), with a 22% share of total imports. It was followed by France, with a 6.9% share.

From 2012 to 2021, the average annual rate of growth in terms of value from Ireland amounted to +8.7%. The remaining supplying countries recorded the following average annual rates of imports growth: Spain (+282.6% per year) and France (-8.9% per year).

Import Prices by Country

The average vaccine import price stood at $X per ton in 2021, growing by 86% against the previous year. Overall, the import price continues to indicate a modest expansion. Over the period under review, average import prices reached the peak figure at $X per ton in 2017; afterwards, it flattened through to 2021.

There were significant differences in the average prices amongst the major supplying countries. In 2021, amid the top importers, the country with the highest price was Spain ($X per ton), while the price for Germany ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by South Africa (+195.4%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

The countries with the highest volumes of in 2021 were Pakistan, Japan and the Philippines, together accounting for 32% of global consumption. These countries were followed by the United States, Indonesia, Spain, China, France, Greece, Brazil, the Netherlands, Turkey and the UK, which together accounted for a further 35%.
The countries with the highest volumes of in 2021 were the United States, Belgium and France, with a combined 56% share of global production. Germany, China, Japan and India lagged somewhat behind, together comprising a further 32%.
In value terms, Ireland constituted the largest supplier of vaccines to Belgium, comprising 44% of total imports. The second position in the ranking was occupied by the United States, with an 18% share of total imports. It was followed by France, with a 13% share.
In value terms, Germany, the United States and Japan constituted the largest markets for vaccines exported from Belgium worldwide, together accounting for 50% of total exports.
The average vaccines export price stood at $1,099,816 per ton in 2021, reducing by -17.5% against the previous year.
The average vaccines import price stood at $1,523 per kg in 2021, waning by -22.9% against the previous year.

This report provides an in-depth analysis of the vaccine market in Belgium. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21202140 -
  • Prodcom 21202145 - Vaccines for human medicine

Country coverage:

  • Belgium

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Belgium
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023

Recommended reports

Free Data: Vaccines For Human Medicine - Belgium